Asymmetry_Informant

Asymmetry_Informant Updated 

Clarity is a clinical-stage radiopharmaceutical company developing targeted theranostics — drugs that combine diagnostic imaging and therapy — using copper isotopes (Cu-64 and Cu-67). SAR-bisPSMA: A dual-function radiopharmaceutical targeting PSMA for both imaging (with 64Cu) and therapy (with 67Cu) in prostate cancer. Est. market entry 2026-2027 ...

Asymmetry_Informant Updated 

Harmonic levels, previous resistance, 50DMA, and 20DMA all point towards the green range. Come June, I think Jerome will continue to cut rates. I will begin accumulating under the 20DMA.

Asymmetry_Informant Updated 

I don't usually post on Trading view so here's a little intro to myself. If you've been following me on Twitter @fintechfin you would know I've been holding a long term position in Chainlink - buying from 0.17c to $1.20. I plan to divest a majority of my capital around 2022 - 2023 as I believe this is when smart contracts will begin to be implemented within...

Asymmetry_Informant Updated 

Good morning. March 4th, what pleasant timing for an announcement. Expect accumulation. Mixicles are SO hot right now. Let's see how this unfolds.

Asymmetry_Informant Updated 

Hi TradingView world. I thought I would touch base with you all again to show you something quite special. First, I'd like you to take a look at my ZOOMED OUT analysis of Chainlink. This should give you some perspective on the fibonacci retracement and some other historical trends shown on my short term trend analysis. Link here: According to my analysis (link...

Asymmetry_Informant

Strong resistance under $270